Predictive diagnostics in colorectal cancer: impact of genetic polymorphisms on individual outcomes and treatment with fluoropyrimidine-based chemotherapy
Standard
Predictive diagnostics in colorectal cancer: impact of genetic polymorphisms on individual outcomes and treatment with fluoropyrimidine-based chemotherapy. / Schwarzenbach, Heidi.
In: EPMA J, Vol. 1, No. 3, 3, 2010, p. 485-494.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
Schwarzenbach, H 2010, 'Predictive diagnostics in colorectal cancer: impact of genetic polymorphisms on individual outcomes and treatment with fluoropyrimidine-based chemotherapy', EPMA J, vol. 1, no. 3, 3, pp. 485-494.
APA
Schwarzenbach, H. (2010). Predictive diagnostics in colorectal cancer: impact of genetic polymorphisms on individual outcomes and treatment with fluoropyrimidine-based chemotherapy. EPMA J, 1(3), 485-494. [3].
Vancouver
Schwarzenbach H. Predictive diagnostics in colorectal cancer: impact of genetic polymorphisms on individual outcomes and treatment with fluoropyrimidine-based chemotherapy. EPMA J. 2010;1(3):485-494. 3.
Bibtex
@article{84be6487dd314a538fb2af6b3dc6bffb,
title = "Predictive diagnostics in colorectal cancer: impact of genetic polymorphisms on individual outcomes and treatment with fluoropyrimidine-based chemotherapy",
author = "Heidi Schwarzenbach",
year = "2010",
language = "Deutsch",
volume = "1",
pages = "485--494",
number = "3",
}
RIS
TY - JOUR
T1 - Predictive diagnostics in colorectal cancer: impact of genetic polymorphisms on individual outcomes and treatment with fluoropyrimidine-based chemotherapy
AU - Schwarzenbach, Heidi
PY - 2010
Y1 - 2010
M3 - SCORING: Zeitschriftenaufsatz
VL - 1
SP - 485
EP - 494
IS - 3
M1 - 3
ER -
